
Sol-Gel Technologies Ltd. SLGL
$ 89.25
-1.44%
Annual report 2024
added 02-21-2026
Sol-Gel Technologies Ltd. P/S Ratio 2011-2026 | SLGL
Annual P/S Ratio Sol-Gel Technologies Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.14 | 25 | 10.9 | 830 | 99.4 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 830 | 5.14 | 194 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Xeris Pharmaceuticals
XERS
|
3.31 | $ 6.03 | -1.55 % | $ 885 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
UroGen Pharma Ltd.
URGN
|
8.41 | $ 19.2 | -11.52 % | $ 554 M | ||
|
uniQure N.V.
QURE
|
38.9 | $ 10.89 | -30.36 % | $ 530 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.74 | 3.6 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
0.00137 | $ 3.36 | 0.86 % | $ 1.2 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
30.2 | $ 29.16 | -3.54 % | $ 1.69 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
1.28 | - | - | - | ||
|
Фармсинтез
LIFE
|
5.39 | - | - | - | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
11.7 | $ 2.19 | -9.77 % | $ 226 M | ||
|
Entera Bio Ltd.
ENTX
|
83.8 | $ 1.38 | -0.72 % | $ 63.3 M | ||
|
Altimmune
ALT
|
23.1 K | $ 4.21 | -2.32 % | $ 299 M | ||
|
Teligent, Inc.
TLGT
|
0.111 | - | -13.85 % | $ 16.1 M | ||
|
Evogene Ltd.
EVGN
|
71.3 | $ 0.84 | -4.24 % | $ 27.9 M | ||
|
Viela Bio, Inc.
VIE
|
36.6 | - | - | $ 2.91 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Amarin Corporation plc
AMRN
|
27.2 | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
AbbVie
ABBV
|
24.1 | $ 233.57 | 0.64 % | $ 413 B | ||
|
Blueprint Medicines Corporation
BPMC
|
11.7 | - | - | $ 8.14 B | ||
|
AIM ImmunoTech
AIM
|
143 | $ 0.8 | -11.6 % | $ 38.5 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.83 | 5.37 % | $ 4.53 M | ||
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.67 | -1.38 % | $ 2.61 B |